|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
N/A |
Shares
Out: |
239,210,000 |
Market
Cap: |
478.42(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.000001 - $0.0721 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane sweetener.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
252,367 |
Total Sell Value |
$0 |
$0 |
$0 |
$304,254 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Valiasek Kathleen |
Chief Financial Officer |
|
2018-05-01 |
4 |
D |
$6.74 |
$3,626 |
D/D |
(538) |
14,630 |
|
- |
|
Cherry Joel |
President of R&D |
|
2018-05-01 |
4 |
D |
$6.74 |
$29,568 |
D/D |
(4,387) |
57,785 |
|
- |
|
Melo John |
President and CEO |
|
2018-01-16 |
4 |
AS |
$4.68 |
$50,436 |
D/D |
(10,776) |
83,172 |
|
- |
|
Maloney Tina |
Chief Accounting Officer |
|
2018-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
Valiasek Kathleen |
Chief Financial Officer |
|
2018-01-02 |
4 |
D |
$4.02 |
$6,545 |
D/D |
(1,628) |
15,168 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-12-01 |
4 |
D |
$3.58 |
$39 |
D/D |
(11) |
9,091 |
|
- |
|
Kung Frank |
Director |
|
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
|
- |
|
Cherry Joel |
President of R&D |
|
2017-11-01 |
4 |
D |
$3.20 |
$1,984 |
D/D |
(620) |
61,345 |
|
- |
|
Melo John |
President and CEO |
|
2017-11-01 |
4 |
D |
$3.20 |
$1,600 |
D/D |
(500) |
93,948 |
|
- |
|
Alvarez Eduardo |
Chief Operating Officer |
|
2017-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
70,000 |
|
- |
|
Doerr L John |
Director |
|
2017-10-09 |
4 |
OE |
$6.30 |
$30,727,526 |
I/I |
4,877,385 |
5,746,558 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-09-01 |
4 |
D |
$2.50 |
$28 |
D/D |
(11) |
9,102 |
|
- |
|
Kelsey Nicole |
General Counsel and Secretary |
|
2017-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
|
- |
|
Koninklijke Dsm N.v. |
|
|
2017-08-08 |
4 |
OE |
$0.00 |
$1,123 |
I/I |
748,728 |
8,684,960 |
|
- |
|
Koninklijke Dsm N.v. |
|
|
2017-08-08 |
4 |
A |
$0.00 |
$0 |
I/I |
7,936,232 |
7,936,232 |
|
- |
|
Reinach Fernando De Castro |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
3,266 |
|
- |
|
Williams R Neil |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
2,866 |
|
- |
|
Al Thani Sheikh Abdullah Bin Khalifa |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
3,066 |
|
- |
|
Eykerman Philip |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
3,133 |
|
- |
|
Piwnica Carole |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
3,266 |
|
- |
|
Klaeijsen Abraham |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
2,466 |
|
- |
|
Doerr L John |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
3,266 |
|
- |
|
Yang Patrick Y |
Director |
|
2017-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,133 |
24,666 |
|
- |
|
Melo John |
President and CEO |
|
2017-06-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,996) |
94,448 |
|
- |
|
Melo John |
President and CEO |
|
2017-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
46,666 |
108,445 |
|
- |
|
406 Records found
|
|
Page 9 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|